VALERIAN 300 MG
VALERIAN : 300 MG · DIN 02246073 · HOLISTA HEALTH (CANADA) INC.
Health Canada status: CANCELLED POST MARKET
What is VALERIAN?
VALERIAN 300 MG contains VALERIAN : 300 MG. It is listed in the Health Canada Drug Product Database under DIN 02246073, held by HOLISTA HEALTH (CANADA) INC., supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Aug-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02246073 |
|---|---|
| Brand name | VALERIAN |
| Generic / active ingredient | VALERIAN : 300 MG |
| Manufacturer | HOLISTA HEALTH (CANADA) INC. |
| Strength | 300 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | N05CM09 VALERIANAE RADIX |
| AHFS class | 28:24.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 04-Aug-2005 |
| Original market date | 2002-09-23 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N05CM09 VALERIANAE RADIX. 0 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ARTRYL CAP 200 MG | 200 MG | CAPSULE | LES LABORATOIRES VACHON INC. | CANCELLED POST MARKET | DIN 02089440 |
| EFFIDOSE VALERIANE LIQ 1916MG/10ML AMP | 1.916 G | LIQUID | LABORATOIRES CHARTON LABORATORIES | CANCELLED POST MARKET | DIN 02052539 |
| ETHICAL HERBALS SLEEP AID | 170 MG | TABLET | ASHBURY RESEARCH CORPORATION | CANCELLED PRE MARKET | DIN 02239995 |
| FACILITE LE SOMMEIL - CAP 270MG | 270 MG | CAPSULE | LABORATOIRE LALCO INC. | CANCELLED POST MARKET | DIN 02228068 |
| HERMES NO6 TEA | 120 MG / 5 ML | TEA (HERBAL) | HERMES ARZNEIMITTEL GMBH | CANCELLED POST MARKET | DIN 00439754 |
| KALM CAPS | 175 MG | CAPSULE | RHEINGOLD FOOD INTERNATIONAL LTD. | CANCELLED POST MARKET | DIN 00628980 |
| PHYTOCALM | 150 MG | CAPSULE | SANTÉ NATURELLE (AG) LTÉE | CANCELLED POST MARKET | DIN 02238752 |
| UNISOM NATURAL SOURCE | 400 MG | CAPSULE | PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION | CANCELLED POST MARKET | DIN 02238837 |
| VALERIANE | 140 MG | TABLET | GAMME NATURE | CANCELLED POST MARKET | DIN 00794481 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.